Business Context and Reporting Period
Company: Peraso Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 5, 2024
Event: Entry into Material Definitive Agreements involving the inducement of warrant holders to exercise existing warrants in exchange for new warrants and a reduced exercise price.
Key Financial Metrics and Transaction Details
- Expected Gross Proceeds: Approximately $2.9 million from the exercise of Existing Warrants by participating holders.
- Use of Proceeds: Working capital and general corporate purposes.
- Transaction Fees:
- Placement Agent Cash Fee: 8.0% of gross proceeds.
- Management Fee: 1.0% of total gross proceeds.
- Expense Reimbursement: Up to $45,000.
- Warrant Exercise Price Reduction: Existing Series B warrants reduced from $2.25 to $1.30 per share for participating holders and non-participating holders.
- New Warrant Issuance:
- Series C Warrants: 2,246,030 shares; Exercise Price $1.61; Term 6 months.
- Series D Warrants: 2,246,030 shares; Exercise Price $1.61; Term 5 years.
- Placement Agent Warrants: 7.0% of shares issued to holders; Exercise Price 125% of reduced price ($1.625); Term 5 years.
Material Changes and Modifications
The filing details a material modification to the rights of security holders regarding existing Series B warrants:
- Price Reduction: The exercise price for all Series B warrant holders (participating and non-participating) was reduced from $2.25 to $1.30 per share.
- Inducement Structure: Participating holders agreed to exercise their warrants for cash at the reduced price in exchange for the issuance of new Series C and Series D warrants.
- Non-Participating Holders: Holders not participating in the offering received the reduced exercise price for the remaining term of their existing warrants without receiving new warrants.
Outlook, Risks, and Restrictions
- Closing Date: Expected on or about November 6, 2024, subject to customary conditions.
- Registration Requirements: The Company must file a resale registration statement within 30 days and use commercially reasonable efforts to have it declared effective within 60 days (or 90 days if reviewed).
- Issuance Restrictions (Lock-up):
- No issuance of Common Stock or equivalents for 30 days following November 5, 2024.
- No Variable Rate Transactions for 120 days following November 5, 2024.
- Call Provision (Series D): The Company may call Series D warrants for cancellation if the stock price exceeds $4.83 for 20 of 30 consecutive trading days and average daily volume exceeds $500,000.
- Ownership Caps: Holders are restricted from exercising warrants if it results in ownership exceeding 4.99% (or 9.99% with notice) of outstanding Common Stock.
Investor Verification Checklist
- Verify the actual closing date and confirmation of the $2.9 million gross proceeds receipt.
- Monitor the filing and effectiveness status of the Resale Registration Statement for New Warrant Shares.
- Review the dilution impact of the 4,492,060 new warrant shares (Series C and D) plus Placement Agent warrants.
- Check for any subsequent filings regarding the 30-day and 120-day issuance restrictions.
- Confirm the treatment of non-participating warrant holders and the total number of shares subject to the reduced $1.30 exercise price.